Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 36 | 2017 | 520 | 3.070 |
Why?
|
| Nephrectomy | 14 | 2022 | 181 | 2.610 |
Why?
|
| Kidney Neoplasms | 13 | 2022 | 460 | 1.890 |
Why?
|
| Ureteral Obstruction | 7 | 2017 | 105 | 1.670 |
Why?
|
| Robotics | 11 | 2022 | 110 | 1.370 |
Why?
|
| Prostatectomy | 15 | 2010 | 356 | 1.220 |
Why?
|
| Carcinoma, Renal Cell | 8 | 2016 | 251 | 1.070 |
Why?
|
| Kidney Pelvis | 4 | 2014 | 46 | 0.800 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2014 | 21 | 0.800 |
Why?
|
| Robotic Surgical Procedures | 4 | 2024 | 234 | 0.790 |
Why?
|
| Para-Aortic Bodies | 1 | 2020 | 2 | 0.700 |
Why?
|
| Kidney Calculi | 2 | 2024 | 48 | 0.660 |
Why?
|
| Hemangioma | 1 | 2020 | 97 | 0.640 |
Why?
|
| Models, Anatomic | 2 | 2018 | 104 | 0.630 |
Why?
|
| Kidney | 6 | 2018 | 1395 | 0.580 |
Why?
|
| Clinical Competence | 6 | 2024 | 1070 | 0.580 |
Why?
|
| Ureter | 3 | 2024 | 100 | 0.570 |
Why?
|
| Lymph Node Excision | 5 | 2006 | 176 | 0.560 |
Why?
|
| Stents | 4 | 2024 | 881 | 0.560 |
Why?
|
| Urologic Surgical Procedures | 6 | 2024 | 59 | 0.560 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2017 | 11 | 0.540 |
Why?
|
| Tomography, Emission-Computed | 1 | 2017 | 39 | 0.530 |
Why?
|
| Silicones | 1 | 2016 | 33 | 0.530 |
Why?
|
| Ureteroscopy | 2 | 2014 | 20 | 0.530 |
Why?
|
| Kidney Diseases | 3 | 2012 | 494 | 0.510 |
Why?
|
| Printing, Three-Dimensional | 1 | 2016 | 70 | 0.490 |
Why?
|
| Diuretics | 1 | 2017 | 168 | 0.490 |
Why?
|
| Simulation Training | 1 | 2018 | 150 | 0.490 |
Why?
|
| Hydrothorax | 1 | 2014 | 11 | 0.450 |
Why?
|
| Respiratory Tract Fistula | 1 | 2014 | 16 | 0.450 |
Why?
|
| Testicular Neoplasms | 2 | 2006 | 131 | 0.450 |
Why?
|
| Urinary Fistula | 1 | 2014 | 20 | 0.450 |
Why?
|
| Ureteral Neoplasms | 1 | 2014 | 27 | 0.440 |
Why?
|
| Organ Sparing Treatments | 1 | 2014 | 45 | 0.430 |
Why?
|
| Precision Medicine | 1 | 2016 | 361 | 0.410 |
Why?
|
| Replantation | 2 | 2011 | 57 | 0.400 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 40 | 0.400 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2020 | 2205 | 0.390 |
Why?
|
| Device Removal | 2 | 2013 | 223 | 0.390 |
Why?
|
| Living Donors | 1 | 2013 | 116 | 0.380 |
Why?
|
| Urology | 4 | 2024 | 86 | 0.380 |
Why?
|
| Male | 48 | 2024 | 65592 | 0.380 |
Why?
|
| Computer Simulation | 3 | 2018 | 708 | 0.370 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2011 | 24 | 0.350 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 24 | 0.350 |
Why?
|
| Ureteral Calculi | 1 | 2010 | 16 | 0.350 |
Why?
|
| Nephrolithiasis | 1 | 2010 | 15 | 0.350 |
Why?
|
| Middle Aged | 35 | 2017 | 28985 | 0.340 |
Why?
|
| Humans | 64 | 2024 | 133373 | 0.330 |
Why?
|
| Cryosurgery | 5 | 2007 | 49 | 0.320 |
Why?
|
| Prostatic Neoplasms | 6 | 2010 | 1606 | 0.320 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 790 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3869 | 0.300 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 255 | 0.300 |
Why?
|
| Urethra | 1 | 2008 | 89 | 0.290 |
Why?
|
| Models, Animal | 3 | 2013 | 483 | 0.290 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 575 | 0.290 |
Why?
|
| Sus scrofa | 1 | 2008 | 125 | 0.290 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 164 | 0.290 |
Why?
|
| Quality of Life | 8 | 2024 | 2168 | 0.270 |
Why?
|
| Adult | 25 | 2022 | 31684 | 0.270 |
Why?
|
| Incidental Findings | 2 | 2020 | 129 | 0.250 |
Why?
|
| Chylous Ascites | 1 | 2006 | 11 | 0.250 |
Why?
|
| Prostate-Specific Antigen | 2 | 2004 | 274 | 0.240 |
Why?
|
| Decision Trees | 1 | 2005 | 51 | 0.240 |
Why?
|
| Germinoma | 1 | 2005 | 32 | 0.240 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2006 | 97 | 0.230 |
Why?
|
| Nephrolithotomy, Percutaneous | 1 | 2024 | 5 | 0.230 |
Why?
|
| Penile Neoplasms | 1 | 2004 | 36 | 0.220 |
Why?
|
| Intestines | 1 | 2008 | 599 | 0.220 |
Why?
|
| Urolithiasis | 2 | 2022 | 9 | 0.220 |
Why?
|
| Uterine Prolapse | 1 | 2004 | 21 | 0.220 |
Why?
|
| Aged | 19 | 2020 | 21500 | 0.220 |
Why?
|
| Perineum | 1 | 2004 | 48 | 0.220 |
Why?
|
| Hospital Charges | 1 | 2004 | 66 | 0.220 |
Why?
|
| Hospitals, Urban | 1 | 2004 | 99 | 0.220 |
Why?
|
| Erectile Dysfunction | 5 | 2018 | 213 | 0.210 |
Why?
|
| Cystectomy | 2 | 2004 | 166 | 0.210 |
Why?
|
| Blood Chemical Analysis | 1 | 2004 | 88 | 0.210 |
Why?
|
| Hospital Costs | 2 | 2005 | 187 | 0.210 |
Why?
|
| Hypogonadism | 2 | 2018 | 320 | 0.210 |
Why?
|
| Sleep | 2 | 2016 | 370 | 0.200 |
Why?
|
| Treatment Outcome | 12 | 2014 | 13103 | 0.200 |
Why?
|
| Penile Erection | 3 | 2010 | 87 | 0.200 |
Why?
|
| Female | 27 | 2024 | 71503 | 0.190 |
Why?
|
| Postoperative Period | 3 | 2017 | 338 | 0.190 |
Why?
|
| Abdomen | 2 | 2020 | 136 | 0.190 |
Why?
|
| Urinary Tract | 1 | 2022 | 68 | 0.180 |
Why?
|
| Female Urogenital Diseases | 1 | 2001 | 8 | 0.180 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 321 | 0.180 |
Why?
|
| Male Urogenital Diseases | 1 | 2001 | 16 | 0.180 |
Why?
|
| Urinary Reservoirs, Continent | 1 | 2001 | 24 | 0.170 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2020 | 12 | 0.170 |
Why?
|
| Urinary Diversion | 1 | 2001 | 44 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2004 | 519 | 0.170 |
Why?
|
| Radionuclide Imaging | 1 | 2020 | 149 | 0.170 |
Why?
|
| Follow-Up Studies | 8 | 2014 | 5443 | 0.160 |
Why?
|
| Prospective Studies | 6 | 2018 | 6582 | 0.160 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2004 | 541 | 0.160 |
Why?
|
| Lymphatic Metastasis | 4 | 2005 | 450 | 0.160 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 1463 | 0.150 |
Why?
|
| Counseling | 1 | 2001 | 240 | 0.150 |
Why?
|
| Young Adult | 4 | 2014 | 9923 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 789 | 0.150 |
Why?
|
| Retrospective Studies | 12 | 2016 | 17568 | 0.150 |
Why?
|
| Mass Screening | 1 | 2004 | 837 | 0.140 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 3105 | 0.140 |
Why?
|
| Internship and Residency | 2 | 2024 | 1253 | 0.130 |
Why?
|
| Radioactive Tracers | 1 | 2017 | 22 | 0.130 |
Why?
|
| Renal Elimination | 1 | 2017 | 10 | 0.130 |
Why?
|
| Prostate | 3 | 2009 | 448 | 0.130 |
Why?
|
| Lithotripsy, Laser | 1 | 2017 | 15 | 0.130 |
Why?
|
| Metabolic Clearance Rate | 1 | 2017 | 143 | 0.130 |
Why?
|
| Patient Selection | 1 | 2001 | 734 | 0.130 |
Why?
|
| Feasibility Studies | 3 | 2016 | 823 | 0.130 |
Why?
|
| Work | 1 | 2016 | 12 | 0.130 |
Why?
|
| Men's Health | 1 | 2016 | 21 | 0.130 |
Why?
|
| Shift Work Schedule | 1 | 2016 | 27 | 0.130 |
Why?
|
| Microbiota | 1 | 2022 | 443 | 0.130 |
Why?
|
| Symptom Assessment | 1 | 2017 | 109 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 132 | 0.130 |
Why?
|
| Aged, 80 and over | 8 | 2012 | 7141 | 0.130 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2016 | 40 | 0.130 |
Why?
|
| Occupational Diseases | 1 | 2016 | 74 | 0.130 |
Why?
|
| Prostatic Hyperplasia | 1 | 2016 | 118 | 0.120 |
Why?
|
| Organ Transplantation | 1 | 2018 | 183 | 0.120 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2016 | 93 | 0.120 |
Why?
|
| Penis | 2 | 2008 | 102 | 0.120 |
Why?
|
| Costs and Cost Analysis | 2 | 2006 | 166 | 0.120 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 3988 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 399 | 0.120 |
Why?
|
| Maryland | 2 | 2006 | 35 | 0.120 |
Why?
|
| Perioperative Care | 2 | 2009 | 212 | 0.120 |
Why?
|
| Blood Loss, Surgical | 3 | 2012 | 158 | 0.120 |
Why?
|
| Thoracostomy | 1 | 2014 | 27 | 0.110 |
Why?
|
| Neoplasm Staging | 5 | 2006 | 1364 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1661 | 0.110 |
Why?
|
| Telemedicine | 1 | 2001 | 507 | 0.110 |
Why?
|
| Sleep Wake Disorders | 1 | 2016 | 188 | 0.110 |
Why?
|
| Intraoperative Complications | 2 | 2006 | 164 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 153 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2013 | 194 | 0.100 |
Why?
|
| Students, Medical | 1 | 2018 | 363 | 0.100 |
Why?
|
| Magnets | 1 | 2013 | 23 | 0.100 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 2142 | 0.100 |
Why?
|
| Needles | 1 | 2013 | 52 | 0.100 |
Why?
|
| Postoperative Complications | 6 | 2014 | 3171 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2014 | 209 | 0.100 |
Why?
|
| Warm Ischemia | 1 | 2012 | 21 | 0.090 |
Why?
|
| S100 Proteins | 1 | 2011 | 47 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 65 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 446 | 0.090 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 109 | 0.090 |
Why?
|
| Urinary Incontinence | 3 | 2008 | 78 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1033 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 49 | 0.090 |
Why?
|
| Impotence, Vasculogenic | 1 | 2010 | 9 | 0.090 |
Why?
|
| Urinalysis | 1 | 2010 | 66 | 0.080 |
Why?
|
| General Surgery | 1 | 2013 | 220 | 0.080 |
Why?
|
| Recurrence | 1 | 2014 | 1469 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 3043 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 162 | 0.080 |
Why?
|
| Retroperitoneal Space | 2 | 2006 | 17 | 0.080 |
Why?
|
| Liver | 2 | 2007 | 1860 | 0.080 |
Why?
|
| Calcinosis | 1 | 2010 | 191 | 0.080 |
Why?
|
| Lung | 2 | 2007 | 1571 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1731 | 0.080 |
Why?
|
| Neoplasm Seeding | 2 | 2005 | 13 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 2288 | 0.070 |
Why?
|
| Intraoperative Period | 3 | 2006 | 73 | 0.070 |
Why?
|
| Urination Disorders | 1 | 2008 | 21 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2014 | 3718 | 0.070 |
Why?
|
| Hemostasis, Surgical | 2 | 2004 | 36 | 0.070 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2007 | 4 | 0.070 |
Why?
|
| Helium | 1 | 2007 | 10 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2007 | 86 | 0.070 |
Why?
|
| Peripheral Nerve Injuries | 2 | 2004 | 40 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2010 | 477 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2013 | 701 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1973 | 0.070 |
Why?
|
| Length of Stay | 4 | 2006 | 1393 | 0.070 |
Why?
|
| Nephrons | 1 | 2006 | 19 | 0.070 |
Why?
|
| Video-Assisted Surgery | 1 | 2006 | 5 | 0.060 |
Why?
|
| Models, Economic | 1 | 2006 | 55 | 0.060 |
Why?
|
| Body Temperature | 1 | 2007 | 128 | 0.060 |
Why?
|
| Ejaculation | 1 | 2006 | 22 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2006 | 53 | 0.060 |
Why?
|
| Hernia, Inguinal | 1 | 2006 | 45 | 0.060 |
Why?
|
| Education, Medical, Continuing | 2 | 2011 | 143 | 0.060 |
Why?
|
| Postoperative Hemorrhage | 1 | 2006 | 84 | 0.060 |
Why?
|
| Aorta, Abdominal | 1 | 2006 | 126 | 0.060 |
Why?
|
| Constipation | 2 | 2004 | 128 | 0.060 |
Why?
|
| Inguinal Canal | 1 | 2004 | 13 | 0.060 |
Why?
|
| Models, Econometric | 1 | 2004 | 9 | 0.060 |
Why?
|
| Cost Allocation | 1 | 2004 | 3 | 0.060 |
Why?
|
| Fees, Medical | 1 | 2004 | 7 | 0.060 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2005 | 64 | 0.060 |
Why?
|
| Equipment Design | 3 | 2013 | 604 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2010 | 373 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2004 | 91 | 0.050 |
Why?
|
| Time Factors | 3 | 2010 | 6544 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2004 | 72 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2004 | 75 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2006 | 248 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2004 | 376 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 310 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2004 | 188 | 0.050 |
Why?
|
| Necrosis | 3 | 2007 | 212 | 0.050 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2004 | 186 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 151 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2004 | 201 | 0.050 |
Why?
|
| Urogenital System | 1 | 2022 | 36 | 0.050 |
Why?
|
| Frozen Sections | 1 | 2001 | 31 | 0.050 |
Why?
|
| Swine | 3 | 2013 | 1205 | 0.050 |
Why?
|
| Acute Disease | 1 | 2004 | 1184 | 0.040 |
Why?
|
| Logistic Models | 3 | 2013 | 1864 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2010 | 5199 | 0.040 |
Why?
|
| Pelvis | 1 | 2001 | 73 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2004 | 568 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1214 | 0.040 |
Why?
|
| Informed Consent | 1 | 2001 | 345 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 20573 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2022 | 795 | 0.030 |
Why?
|
| Organ Size | 2 | 2009 | 464 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 1013 | 0.030 |
Why?
|
| Animals | 5 | 2013 | 36222 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2001 | 578 | 0.030 |
Why?
|
| Graft Survival | 1 | 2018 | 482 | 0.030 |
Why?
|
| Hernia, Obturator | 1 | 1975 | 5 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 1849 | 0.030 |
Why?
|
| Hernia | 1 | 1975 | 17 | 0.030 |
Why?
|
| Infertility, Male | 1 | 2018 | 296 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2018 | 337 | 0.030 |
Why?
|
| Self Report | 1 | 2016 | 553 | 0.030 |
Why?
|
| United States | 2 | 2024 | 11722 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 182 | 0.020 |
Why?
|
| Risk Factors | 3 | 2016 | 10954 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2005 | 1584 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2018 | 887 | 0.020 |
Why?
|
| Alprostadil | 1 | 2010 | 26 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 129 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 190 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1124 | 0.020 |
Why?
|
| Health Surveys | 1 | 2010 | 260 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 213 | 0.020 |
Why?
|
| Health Status | 1 | 2010 | 414 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 44 | 0.020 |
Why?
|
| Thermometers | 1 | 2007 | 9 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 1254 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 88 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 234 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 27 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 13243 | 0.020 |
Why?
|
| Diagnostic Techniques, Surgical | 1 | 2006 | 2 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1353 | 0.020 |
Why?
|
| Laparoscopes | 1 | 2006 | 5 | 0.020 |
Why?
|
| Prognosis | 2 | 2006 | 5044 | 0.020 |
Why?
|
| Child | 2 | 2022 | 25868 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2007 | 245 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 427 | 0.010 |
Why?
|
| Electrosurgery | 1 | 2004 | 17 | 0.010 |
Why?
|
| Ultrasonic Therapy | 1 | 2004 | 29 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 2004 | 39 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2006 | 463 | 0.010 |
Why?
|
| Dissection | 1 | 2004 | 58 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2005 | 238 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 517 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2004 | 288 | 0.010 |
Why?
|
| Dogs | 1 | 2004 | 672 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 965 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 562 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 723 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2005 | 279 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 1469 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 2956 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 2207 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 1313 | 0.010 |
Why?
|
| Nausea | 1 | 1975 | 87 | 0.010 |
Why?
|
| Intestinal Obstruction | 1 | 1975 | 96 | 0.010 |
Why?
|